59227-67-7

Basic information

• Product Name: 1-(5-bromothiophen-3-yl)ethanone
• Synonyms: 1-(5-bromothiophen-3-yl)ethanone;1-(5-broMothiophen-3-yl)ethan-1-one;1-(5-bromo-3-thienyl)ethanone;3-Acetyl-5-bromothiophene;4-Acetyl-2-bromothiophene;1-(5-Bromothiophen-3-yl)
• CAS NO: 59227-67-7
• Molecular Formula: C₆H₅BrOS
• Molecular Weight: 205.0723
• Mol File: 59227-67-7.mol
• Article Data: 7

Chemical Properties

• Melting Point: 63-64 °C
• Boiling Point: 258.695 °C at 760 mmHg
• Flash Point: 110.255 °C
• Appearance: /
• Density: 1.619 g/cm³
• Vapor Pressure: 0.014mmHg at 25°C
• Refractive Index: 1.584
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: 1-(5-bromothiophen-3-yl)ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(5-bromothiophen-3-yl)ethanone(59227-67-7)
• EPA Substance Registry System: 1-(5-bromothiophen-3-yl)ethanone(59227-67-7)

Safety Data

• Hazardous Substances Data: 59227-67-7(Hazardous Substances Data)

Usage

General Description

1-(5-Bromothiophen-3-yl)ethanone is a chemical compound with the molecular formula C8H7BrOS. It is a yellow to brown liquid with a strong, pungent odor. 1-(5-Bromothiophen-3-yl)ethanone is used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also used in the production of organic compounds and as a reagent in chemical reactions. 1-(5-Bromothiophen-3-yl)ethanone is considered to be potentially harmful if ingested, inhaled, or absorbed through the skin, and proper safety measures should be taken when handling it.

InChI:InChI=1/C6H5BrOS/c1-4(8)5-2-6(7)9-3-5/h2-3H,1H3

Upstream product

• 88-15-3 2-Acetylthiophene 
• 1468-83-3 1-(thiophen-3-yl)-ethanone 
• 128-08-5 N-Bromosuccinimide 

Downstream Products

• 1049657-23-9 C₁₇H₁₆N₄OS 
• 38071-61-3 1-(5-phenylthiophen-3-yl)ethan-1-one 
• 171482-65-8 (S)-4'-<<4-(2,2,4-trimethyl-1,3-dioxolan-4-yl)thien-2-yl>thio>acetophenone oxime 
• 161387-22-0 (S)-4'-<<4-(2,2,4-trimethyl-1,3-dioxolan-4-yl)thien-2-yl>thio>acetophenone 
• 171482-66-9 (S)-4'-<<4-(2,2,4-trimethyl-1,3-dioxolan-4-yl)thien-2-yl>thio>acetophenone O-(cyanomethyl)oxime 

Relevant articles and documents

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

The present invention is directed to inhibitors of S-nitrosoglutathione reductase (GSNOR), pharmaceutical compositions comprising such GSNOR inhibitors, and methods of making and using the same.

Discovery of an orally available, brain penetrant BACE1 inhibitor that affords robust CNS Aβ reduction

Inhibition of BACE1 to prevent brain Aβ peptide formation is a potential disease-modifying approach to the treatment of Alzheimer's disease. Despite over a decade of drug discovery efforts, the identification of brain-penetrant BACE1 inhibitors that substantially lower CNS Aβ levels following systemic administration remains challenging. In this report we describe structure-based optimization of a series of brain-penetrant BACE1 inhibitors derived from an iminopyrimidinone scaffold. Application of structure-based design in tandem with control of physicochemical properties culminated in the discovery of compound 16, which potently reduced cortex and CSF Aβ40 levels when administered orally to rats.

Antibacterial agents

The present invention provides compounds of formula (I): wherein R1-R6 and J and K have any of the values defined in the specification, and pharmaceutically acceptable salt thereof, that are useful as antibacterial agents. Also disclosed are pharmaceutical compositions comprising one or more compounds of formula I, processes for preparing compounds of formula I, and intermediates useful for preparing compounds of formula I.